Cargando…
Deterioration of Cycloserine in Drug Susceptibility Testing of Mycobacterium
PURPOSE: Cycloserine is an effective group C anti-tuberculosis drug. But the reliability and reproducibility of drug susceptibility tests (DST) for this drug cannot be guaranteed and provide poor clinical predictive values. However, DST of cycloserine in practice provides rough estimate of the drug...
Autores principales: | Wang, Ruibai, Zhao, Xiuqin, Wan, Kanglin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763265/ https://www.ncbi.nlm.nih.gov/pubmed/35046677 http://dx.doi.org/10.2147/IDR.S348428 |
Ejemplares similares
-
In Vitro Activity of β-Lactams in Combination with β-Lactamase Inhibitors against Mycobacterium tuberculosis Clinical Isolates
por: Li, Fu, et al.
Publicado: (2018) -
A New Single Gene Differential Biomarker for Mycobacterium tuberculosis Complex and Non-tuberculosis Mycobacteria
por: Zhou, Lei, et al.
Publicado: (2019) -
A novel multistage antigens ERA005f confer protection against Mycobacterium tuberculosis by driving Th-1 and Th-17 type T cell immune responses
por: Fan, Xueting, et al.
Publicado: (2023) -
Drug Susceptibility Testing of 31 Antimicrobial Agents on Rapidly Growing Mycobacteria Isolates from China
por: Pang, Hui, et al.
Publicado: (2015) -
Role of Alanine Racemase Mutations in Mycobacterium tuberculosis
d-Cycloserine Resistance
por: Nakatani, Yoshio, et al.
Publicado: (2017)